Control of Cyclin D1 and Breast Tumorigenesis by the EglN2 Prolyl Hydroxylase
Qing Zhang(Southwestern Medical Center), Archana Bommi‐Reddy(Morpho (United States)), Lianjie Li(Regeneron (United States)), Myles Brown(Harvard University), Jinming Gu(Brigham and Women's Hospital), William C. Hahn(Broad Institute), Jiayun Liu(Harvard University), Min Ni(Weifang Medical University), David E. Root(Broad Institute), William G. Kaelin(Broad Institute), Christoph Geisen(Harvard University), Biao Luo(Broad Institute), H.F.J Cheung(Broad Institute), Kornélia Polyák(Dana-Farber Cancer Institute), Andrea L. Richardson(Brigham and Women's Hospital), Jesse S. Boehm(Massachusetts Institute of Technology)
Cited by 142
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k